VHCP Management as of June 30, 2016
Portfolio Holdings for VHCP Management
VHCP Management holds 23 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dbv Technologies | 30.2 | $29M | 457k | 63.72 | |
| Heron Therapeutics (HRTX) | 20.5 | $20M | 1.1M | 18.05 | |
| Coherus Biosciences (CHRS) | 10.7 | $10M | 611k | 16.89 | |
| Flamel Technologies | 5.6 | $5.4M | 500k | 10.74 | |
| Zafgen | 3.7 | $3.6M | 602k | 5.99 | |
| Adverum Biotechnologies | 3.6 | $3.5M | 1.1M | 3.16 | |
| BioCryst Pharmaceuticals (BCRX) | 3.0 | $2.9M | 1.0M | 2.84 | |
| Alcobra | 2.9 | $2.8M | 623k | 4.49 | |
| Lipocine | 2.7 | $2.6M | 850k | 3.04 | |
| Axovant Sciences | 2.5 | $2.4M | 184k | 12.84 | |
| Akari Therapeutics | 2.2 | $2.1M | 158k | 13.49 | |
| Cynapsus Therapeutics | 1.9 | $1.8M | 109k | 16.63 | |
| Beigene (BGNE) | 1.6 | $1.5M | 51k | 29.80 | |
| Ocera Therapeutics | 1.6 | $1.5M | 797k | 1.90 | |
| Edge Therapeutics | 1.4 | $1.4M | 135k | 10.11 | |
| ARCA biopharma | 1.4 | $1.3M | 462k | 2.90 | |
| Global Blood Therapeutics In | 1.2 | $1.2M | 73k | 16.59 | |
| Ascendis Pharma A S (ASND) | 1.2 | $1.2M | 90k | 13.27 | |
| D Stemline Therapeutics | 0.9 | $917k | 135k | 6.77 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $656k | 64k | 10.22 | |
| Regenxbio Inc equity us cm (RGNX) | 0.4 | $420k | 53k | 8.00 | |
| Pronai Therapeutics | 0.1 | $112k | 56k | 2.00 | |
| Aeglea Biotherapeutics | 0.0 | $29k | 6.0k | 4.83 |
